Atlas Trials

Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors

Clinical trial NCT05963386 · COMPLETED

Trial details

NCT number
NCT05963386
Sponsor
The First Affiliated Hospital of Xiamen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory Solid Tumor
Start date
2022-02-22
Primary completion
2024-09-15
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.